卡培他滨 (Chinese Wikipedia)
Analysis of information sources in references of the Wikipedia article "卡培他滨" in Chinese language version.
refsWebsite
Global rank
Chinese rank
1st place
1st place
6th place
4th place
3,823rd place
3,456th place
3,984th place
1,603rd place
719th place
889th place
3rd place
8th place
102nd place
492nd place
low place
low place
archive.org
- British national formulary : BNF 69 69. British Medical Association. 2015: 585, 588. ISBN 9780857111562.
books.google.com
- Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 511 [2017-08-30]. ISBN 9783527607495. （原始内容存档于2023-01-12）.
doi.org
- Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clinical Pharmacology and Therapeutics. December 2013, 94 (6): 640–645. PMC 3831181
. PMID 23988873. doi:10.1038/clpt.2013.172. - Amstutz U, Froehlich TK, Largiadèr CR. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics. September 2011, 12 (9): 1321–1336. PMID 21919607. doi:10.2217/pgs.11.72.
drugs.com
- Capecitabine. The American Society of Health-System Pharmacists. [2016-12-08]. （原始内容存档于2016-04-15）.
europa.eu
ema.europa.eu
- Capecitabine Teva : EPAR – Product Information (PDF). European Medicines Agency. Teva Pharma B.V. 10 January 2014 [2014-01-25]. （原始内容存档 (PDF)于2014-02-04）.
fda.gov
- FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal. U.S. Food and Drug Administration. 2022-12-15 [2023-01-26]. （原始内容存档于2023-01-27）.
本文含有此來源中屬於公有领域的内容。
gene.com
- . Greentech https://www.gene.com/patients/medicines/xeloda. [2024-04-05]. （原始内容存档于2014-02-08）. 缺少或
|title=为空 (帮助)
handle.net
hdl.handle.net
- World Health Organization. World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
indiamart.com
- Capecitabine Tablets. indiamart. [2024-04-05]. （原始内容存档于2024-04-05）.
medicines.org.uk
- Capecitabine 150mg – Summary of Product Characteristics (SPC). electronic Medicines Compendium. Zentiva. 23 December 2013 [2014-01-25]. （原始内容存档于2014-02-01）.
medscape.com
reference.medscape.com
- Xeloda (capecitabine) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. 2014-01-25. （原始内容存档于2014-02-02）.
nih.gov
ncbi.nlm.nih.gov
- Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M. Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clinical Pharmacology and Therapeutics. December 2013, 94 (6): 640–645. PMC 3831181 . PMID 23988873. doi:10.1038/clpt.2013.172.
- Amstutz U, Froehlich TK, Largiadèr CR. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity. Pharmacogenomics. September 2011, 12 (9): 1321–1336. PMID 21919607. doi:10.2217/pgs.11.72.
dailymed.nlm.nih.gov
- XELODA (capecitabine) tablet, film coated [Genentech, Inc.]. DailyMed. Genentech, Inc. December 2013 [2014-01-25]. （原始内容存档于2014-02-01）.
tga.gov.au
ebs.tga.gov.au
- NAME OF THE MEDICINE XELODA® Capecitabine (PDF). TGA eBusiness Services. Roche Products Pty Limited. 2013-12-05 [2014-01-25]. （原始内容存档于2017-09-11）.
web.archive.org
- Capecitabine. The American Society of Health-System Pharmacists. [2016-12-08]. （原始内容存档于2016-04-15）.
- FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal. U.S. Food and Drug Administration. 2022-12-15 [2023-01-26]. （原始内容存档于2023-01-27）. 本文含有此來源中屬於公有领域的内容。
- XELODA (capecitabine) tablet, film coated [Genentech, Inc.]. DailyMed. Genentech, Inc. December 2013 [2014-01-25]. （原始内容存档于2014-02-01）.
- Capecitabine Teva : EPAR – Product Information (PDF). European Medicines Agency. Teva Pharma B.V. 10 January 2014 [2014-01-25]. （原始内容存档 (PDF)于2014-02-04）.
- Capecitabine 150mg – Summary of Product Characteristics (SPC). electronic Medicines Compendium. Zentiva. 23 December 2013 [2014-01-25]. （原始内容存档于2014-02-01）.
- NAME OF THE MEDICINE XELODA® Capecitabine (PDF). TGA eBusiness Services. Roche Products Pty Limited. 2013-12-05 [2014-01-25]. （原始内容存档于2017-09-11）.
- Xeloda (capecitabine) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. 2014-01-25. （原始内容存档于2014-02-02）.
- Fischer J, Ganellin CR. Analogue-based Drug Discovery. John Wiley & Sons. 2006: 511 [2017-08-30]. ISBN 9783527607495. （原始内容存档于2023-01-12）.
- . Greentech https://www.gene.com/patients/medicines/xeloda. [2024-04-05]. （原始内容存档于2014-02-08）. 缺少或
|title=为空 (帮助) - Capecitabine Tablets. indiamart. [2024-04-05]. （原始内容存档于2024-04-05）.